{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-034848","form_type":"8-K","ticker":"PHIO","cik":"0001533040","company_name":"Phio Pharmaceuticals Corp.","filed_at":"2025-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.664866+00:00","generated_at":"2026-05-16T20:20:47.804846+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Phio Pharma Q3 net loss $2.4M; PH-762 trial 100% tumor clearance at max dose","bullets":["Net loss $2.4M for Q3 2025 vs $1.5M in Q3 2024; R&D expenses $1.2M, G&A $1.3M.","Phase 1b PH-762 trial: 100% tumor clearance (complete response) in one patient at max dose, >90% in second, >50% in third.","Cumulative pathologic results in 16 cSCC patients: 6 complete, 2 near complete, 2 partial responses; no dose-limiting toxicities.","November 2025 warrant inducement financing expected to raise ~$12.1M, extending cash runway into first half 2027.","Cash and equivalents $10.7M at Sep 30, 2025; estimated $21.3M as of release date."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-034848","json":"https://secwatch.observer/filing/0001437749-25-034848.json","markdown":"https://secwatch.observer/filing/0001437749-25-034848.md","text":"https://secwatch.observer/filing/0001437749-25-034848.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533040/000143774925034848/0001437749-25-034848-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533040/000143774925034848/phio20251001_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T20:20:47.804846+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}